Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2021-03-29 Management Reports
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2020年监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2020 年监事会工作报告" (2020 Supervisory Board Work Report) of 启迪药业集团股份公司. It details the activities and oversight performed by the supervisory board during 2020, including meetings held, review of financial reports (2019 annual report, 2020 quarterly and half-year reports), internal control evaluations, and audit report reviews. The document is a comprehensive report on the supervisory board's work and opinions on company operations, financial management, internal controls, and compliance. It is not a simple announcement or a brief summary but a detailed report. The content aligns with a Management Report (MDA) as it provides management's detailed explanation and oversight of financial results, business trends, and governance during the period. The document length is 4115 characters, which is substantial for a report but not extremely long. It is not an Annual Report (10-K) or Audit Report (AR) itself but a supervisory board report commenting on these. Therefore, the best fitting category is Management Reports (MDA).
2021-03-29 Chinese
关于2021年度日常关联交易预计公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the year 2021. It includes descriptions of the nature of the transactions, parties involved, pricing, authorization, and independent director opinions. The document is not a financial report, audit report, or earnings release. It is a regulatory announcement about related party transactions, which is a common type of regulatory filing in Chinese listed companies. The document length is 3740 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is an annual report, interim report, or any other financial statement. It is not a voting result, board change, or capital update. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-03-29 Chinese
关于使用部分闲置募集资金购买保本型理财产品的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from a company about the decision to use part of its idle raised funds to purchase principal-guaranteed financial products. It includes information about the raised funds, usage, investment purpose, amount, types of products, risk control measures, and opinions from independent directors and the supervisory board. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory announcement related to the use of raised funds and investment decisions, complying with regulatory requirements and disclosing relevant details. This fits best under the category of Regulatory Filings (RNS), as it is a compliance and disclosure announcement that does not fit into more specific categories like Capital/Financing Update or Earnings Release.
2021-03-29 Chinese
年度募集资金使用鉴证报告
Regulatory Filings
2021-03-29 Chinese
董事会秘书工作制度
Governance Information Classification · 95% confidence The document is titled '董事会秘书工作制度' which translates to 'Board Secretary Work System'. It details the duties, appointment, qualifications, responsibilities, performance evaluation, and internal accountability of the company's board secretary. The content focuses on governance practices, compliance with laws and regulations, and internal control mechanisms related to the board secretary role. There is no financial data, earnings information, or report publication announcement. The document is a governance-related internal policy or procedural document. Therefore, it fits best under Governance Information (CGR). The document length (6598 characters) and detailed procedural content support this classification with high confidence.
2021-03-29 Chinese
独立董事关于第九届董事会第三次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a pre-approval opinion from independent directors regarding a specific agenda item for the company's ninth board meeting, specifically about the 2021 annual routine related-party transaction limit proposal. It is not a full report but a governance-related opinion on board matters. There is no financial data or detailed report content, and it relates to board meeting matters and governance. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on board approval matters, not a full report or announcement.
2021-03-29 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.